Primary Record
Erlotinib
- In stock
- 5,251 g
- Purity
- 99.3 %
- CAS
- 183321-74-6
Compound Identifiers & Properties
- CAS
- 183321-74-6
- PubChem CID
- 176870
- SMILES
- COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
- Canonical SMILES
- C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
Names & Synonyms
- Erlotinib
- Tarceva
- 183321-74-6
- Erlotinib Base
- erlotinibum
- Erlotinib free base
- Erlotinib hydrochloride
- Erlotinib [INN]
- Erlotinin
- Erotinib
- erlotinib;
- erlotinib HCl
- Erlotinib(Tarceva)
- Erlotinib (INN)
- Erlotinib, Free Base
- N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
- Tarceva (TN)
- nchembio866-comp3
- Erlotinib, OS-774
- Erlotinib [INN:BAN]
- Erlotinib free base?
- Erlotinib (Standard)
- J4T82NDH7E
- RefChem:5799
- Kinome_3317
- OSI-774
- CHEMBL553
- UNII-J4T82NDH7E
- ERLOTINIB [MI]
- MFCD02089651
- ERLOTINIB [VANDF]
- DTXSID8046454
- D07POC
- Erlotinib hydrochloride CRS
- AC1L42EI
- ERLOTINIB [WHO-DD]
- SCHEMBL8413
- C22H23N3O4
- DTXCID6026454
- ERLOTINIB [EMA EPAR]
- Erlotinib HCL Intermediate 3
- HSDB 8082
- CHEBI:114785
- OSI 744
- 183321-74-6 (free base)
- BDBM5446
- cid_176870
- GTPL4920
- orb1310678
- QUI124
- Erlotinib, 98% - 1G 1g
- Tyrosine Kinase Inhibitor - Ns
- 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
- Erlotinib Hydrochloride -Form A
- NSC 718781
- SCHEMBL29351329
- SCHEMBL30362833
- 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline
- RG-1415
- CP-358774
- L01XE03
- OSI-744
- QCR-100
- AAKJLRGGTJKAMG-UHFFFAOYSA-N
- s7786
- 2-Boc-amino-4-bromomethylpyridine
- HMS2089F05
- HMS3244M19
- HMS3244M20
- HMS3244N19
- HMS3295A19
- HMS3713C22
- HMS3745M05
- HMS5085P20
- N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
- AMX10161
- MSK10717
- ZINC1546066
- Tox21_112202
- 3615AH
- AC-399
- CID176870
- EBC-00690
- FC0029
- HY-50896R
- NCGC00164574-01
- NSC718781
- NSC800097
- R-1415
- STK623143
- CP-358,774
- CP358774
- AKOS000282911
- C22-H23-N3-O4
- CP-35877401
- Tox21_112202_1
- ACN-036244
- CCG-220420
- CS-0620
- CS-O-31362
- DB00530
- NSC-718781
- NSC-800097
- RL02337
- Ro-508231
- SB16916
- SDCCGSBI-0634409.P005
- NCGC00164574-03
- NCGC00164574-05
- NCGC00164574-06
- NCGC00164574-14
- NCGC00164574-25
- AJ-26877
- AK142763
- AN-15876
- AS-35132
- BC215797
- BCB03_000783
- BE164419
- BP-43654
- CJ-05292
- EN002711
- HY-50896
- P443
- SY028059
- R 1415
- AB0017012
- AB1004620
- J910.423B
- LS-184395
- 2159B
- A3397
- AM20090621
- CAS-183321-74-6
- CP 358,774
- FT-0651539
- NS00006169
- ST24046689
- KS-00000642
- [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE
- A11416
- D07907
- EN300-708808
- K00241
- S-7717
- 15214-EP2269994A1
- 15214-EP2272827A1
- 15214-EP2281815A1
- 15214-EP2292234A1
- 15214-EP2292615A1
- 15214-EP2295432A1
- 15214-EP2298778A1
- 15214-EP2301533A1
- 15214-EP2301933A1
- 15214-EP2305640A2
- 15214-EP2305671A1
- 15214-EP2305687A1
- 15214-EP2308855A1
- 15214-EP2311827A1
- 15214-EP2311840A1
- 15214-EP2311842A2
- 15214-EP2316832A1
- 15214-EP2316833A1
- 32334-EP2281815A1
- 32334-EP2292615A1
- 32334-EP2301933A1
- 32334-EP2305640A2
- 32334-EP2305671A1
- 32334-EP2311827A1
- AB01273955-01
- AB01273955-02
- AB01273955-03
- CP-358,774-01
- 134172-EP2292233A2
- 321E746
- A812764
- F050702
- Q418369
- SR-05000001460
- 183319-69-9
- I01-1241
- SR-05000001460-1
- SR-05000001460-2
- SR-05000001460-3
- SR-05000001460-6
- [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine
- BRD-K70401845-001-15-7
- BRD-K70401845-003-04-7
- BRD-K70401845-003-09-6
- Z2588038919
- 4-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)quinazoline
- AQ4
- 4-(3-Ethynylphenylamino)-6,7-bis(3-oxabutane-1-yloxy)quinazoline
- 4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
- n-(3-ethynylphenyl)(6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amine
- n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazoline-4-amine
- n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine
- (6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine
- 1429636-49-6
- Erlortinib; 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline
- 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)
- n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride
- 4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine; Erlotinin; Erlotinib Base
- Erlotinib; 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; NSC 718781; OSI 744; R 1415